Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Allogeneic, BCMA, CAR-T, CD19 Oct 02 | 2020Precision Biosciences Highlights First Patient Dosed with BCMA CAR-T PBCAR269A; PBCAR0191 Clinical Updates Delayed to YE; Q2 2020 Earnings SummaryPurchase Blast
$599
Posted in: Other Oct 01 | 2020Provention Bio Launches T1DM Screening Awareness CampaignPurchase Blast$599
Posted in: Other Sep 30 | 2020Provention Bio Files Teplizumab Clinical Module; ADA 2021 PDUFA Possible?Purchase Blast
$599
Posted in: Autologous, BCMA, CAR-T Sep 30 | 2020Legend Biotech Highlights FDA Filing of Cilta-Cel by YE 2020; Q2 2020 Earnings SummaryPurchase Blast
$599
Posted in: Other Sep 30 | 2020DreaMed Partners with Four Additional US Health ClinicsPurchase Blast
$599
Posted in: Glucose Monitoring, Other, SGLT2i Sep 29 | 2020Dexcom Publishes G6 UK Cost-Effectiveness Data and Launches G6 in Turkey; Lifescan Launches OneTouch Amazon Storefront; Daewoong Pharma Announces Ph2 Results for Enavogliflozin; Zucara Therapeutics Doses First Patient in Preventative Hypo StudyPurchase Blast
$599
Posted in: GLP-1RA, SGLT2i Sep 25 | 2020New Semaglutide HFpEF Trial (STEP HFpEF); DAPA-MI Posted on CT.gov; Final Day of EASD 2020 (Sept 25)Purchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Sep 24 | 2020Dexcom Partners with UVA, Novo CVD Real-world Treatment Study, Movano Partners for Smartwatch CGM; Imeglimin Ph3 Data; EASD 2020 Key Press Releases (Sept 24)Purchase Blast
$599
Posted in: GLP-1RA, Other Sep 23 | 2020FDA Launches Digital Health Center of Excellence; Novo Initiates New Ozempic and Rybelsus Trials; vTv Presents TTP399 Data; EASD 2020 Key Press Releases (Sept 23)Purchase Blast
$599
Posted in: Autologous, BCMA Sep 22 | 2020BMS and bluebird bio Receive Priority Review for Ide-cel; PDUFA Projected Around March 27, 2021Purchase Blast$599
Posted in: Basal Insulin, GLP-1RA, Glucose Monitoring Sep 22 | 2020New Novo QW Insulin Icodec Data; Novo Updates Rybelsus Website; Dexcom G6 VA Pharmacy Distribution; Ascensia Partners to Accelerate Data Strategy; REWIND Canada Approval; Oramed ORMD-0801 NASH Data; EASD 2020 Key Press Releases (Sept 22)Purchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Sep 21 | 2020Insulet Expands DASH Availability in Europe; Nemaura In-Licenses Healthimation Diabetes App; Dario Enters Distribution Agreement with HMC; Arecor uRAI to be Presented Tomorrow; Adocia to Host Business Review; EASD 2020 Key Press Releases (Sept 21)Purchase Blast
$599
Posted in: Autologous, CD19, CD22 Sep 21 | 2020Updated AUTO3 Ph1/2 ALEXANDER Results; ESMO 2020 Investor Call SummaryPurchase Blast
$599
Posted in: Glucose Monitoring Sep 18 | 2020Medtronic Recalls Guardian Connect App After Data Upload DisruptionsPurchase Blast
$599
Posted in: Other Sep 18 | 2020Diamyd to Move Forward with Ph3 Trial in HLA-Present T1DM Subpopulation; Additional Results from DIAGNODE-2Purchase Blast
$599
Posted in: CAR-T, CD123, CD22, CS1 Sep 18 | 2020Thoughts on Cellectis’s CAR-T Program; Potential UCARTCS1 Protocol Changes; Q2 2020 Earnings CallPurchase Blast
$599
Posted in: Glucose Monitoring Sep 17 | 2020Abbott to Launch the First "Glucose Sport Biosensor"Purchase Blast
$599
Posted in: Glucose Monitoring, Other Sep 17 | 2020Dexcom Announces New CGM Registry and Global Business Service Site in Lithuania; Dario Appoints Former LifeScan Exec to Scientific Advisory BoardPurchase Blast
$599
Posted in: Other Sep 16 | 2020Japanese NDA Submitted for Imeglimin; Poxel H1 '20 Earnings UpdatePurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
